Moreover, the binding of these compounds with some other G-quadruplex DNA, Bcl-2, kras, VEGF, c-kit1 and telomeric may also have occurred, since it is difficult to distinguish different G-quadruplex DNAs that originate from different tumor cells, and this will be investigated in our future studies. This evidence concerns the gene KRAS and neoplasm.